Novel GLP-1 Analogues
Sun Pharmaceutical Industries, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 16/376,190, filed Apr 5, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,242,373 | Novel GLP-1 Analogues In force · High confidence UsedRemaining | Sun Pharmaceutical Industries Limited | In force | High confidence | ||
| US 11,447,535 | Novel GLP-1 Analogues In force · High confidence | Sun Pharmaceutical Industries Limited | In force | High confidence | ||
| US 11,866,477 | Novel GLP-1 Analogues In force · High confidence | Sun Pharmaceutical Industries Limited | In force | High confidence | ||
| US 11,873,328 | Novel GLP-1 Analogues In force · High confidence | Sun Pharmaceutical Industries Limited | In force | High confidence | ||
| US 12,421,289 | GLP-1 Analogues In force · High confidence | Sun Pharmaceutical Industries Limited | In force | High confidence | ||
| US 11,485,766 | Novel GLP-1 Analogues In force · High confidence | Sun Pharmaceutical Industries Limited | In force | High confidence | ||
| Application 18/667,531 | Novel GLP-1 Analogues Pending Not granted | Sun Pharmaceutical Industries limited | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Sun Pharmaceutical Industries, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.